Search Login Register

adalimumab (Humira) Summary

Description: a fully humanized anti-TNFalpha monoclonal antibody

Also Known As: Humira; Abbott brand of adalimumab; D2E7 antibody

Networked: 2321 relevant articles (461 outcomes, 464 trials/studies) for this Drug

Key Diseases for which adalimumab is Relevant

  1. Crohn Disease (Crohn's Disease) : 129 outcomes 85 studies in 460 results
  2. Psoriasis (Pustulosis Palmaris et Plantaris) : 96 outcomes 102 studies in 462 results
  3. Rheumatoid Arthritis : 60 outcomes 120 studies in 572 results
  4. Ulcerative Colitis : 35 outcomes 24 studies in 124 results
  5. Ankylosing Spondylitis : 30 outcomes 35 studies in 137 results
Show All >>

Drugs Related to adalimumab

  1. infliximab (Remicade)
  2. TNFR-Fc fusion protein (etanercept)
  3. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  4. Methotrexate (Mexate)
  5. CDP870
  6. golimumab
  7. monoclonal antibody CNTO 1275 (CNTO 1275)
  8. Phenobarbital (Luminal)
  9. Azathioprine (Imuran)
  10. Antirheumatic Agents (DMARD)
Show All >>

Therapies Related to adalimumab

  1. Biological Therapy
  2. Drug Therapy (Chemotherapy)
  3. Retreatment
  4. Aftercare (After-Treatment)
  5. Injections
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.